key: cord-0942951-nnosjmv6
authors: Nau, Claudia; Bruxvoort, Katia; Navarro, Ronald A.; Chevez, Shari G.; Hogan, Tiffany A.; Ironside, Kristen R.; Ludwig, Stacey M.; Ngo-Metzger, Quyen; Mourra, Natalie R.; Young, Deborah Rohm; Sangha, Navdeep; Turner, Branden P.; Li, Iona (Xia); Padilla, Ariadna; Chen, Aiyu; Hong, Vennis; Yau, Vincent; Tartof, Sara
title: COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization
date: 2021-04-20
journal: Ann Intern Med
DOI: 10.7326/m20-8283
sha: 8a6df2b78fbd425dfaf513a1457c47f96a194301
doc_id: 942951
cord_uid: nnosjmv6

nan

COVID-19 cases were identified between 1 March and 31 July 2020. The cohort was followed until 11 September 2020 to observe hospitalizations or intensive-level care outcomes. COVID-19 hospitalizations were defined as a KPSC hospitalization occurring within 21 d of a COVID-19 diagnosis or positive test result. Intensive-level care was defined as a high (1:1 or 2:1) patient-nurse ratio or receipt of either high-flow oxygen or mechanical ventilation-as indicated by nursing flow sheets. ‡ The 5 broad comorbidity categories are created by aggregating the following Elixhauser comorbidities: "cardiovascular diseases" includes congestive heart failure, cardiac arrhythmia, valvular disease, pulmonary circulation disorders, and peripheral vascular disorders; "pulmonary disease" includes chronic pulmonary disease; "hypertension" includes uncomplicated and complicated hypertension; "diabetes" includes diabetes with and without chronic complications; and the remaining Elixhauser comorbidities were grouped as "other."

This article was published at Annals.org on 20 April 2021. categories (Table) (2). For each race/ethnicity, we estimated the RR of an event occurring, with being White as the reference category. We also provide the adjusted marginal probability of each outcome, expressed as percentages for ease of interpretation. This research was approved by the KPSC Institutional Review Board.

Findings: We identified 47 974 COVID-19 cases; 4517 (9.42%) required hospitalization and 1498 (3.12%) required intensive-level care (Table) . Patients who required hospitalization and intensive-level care were on average older, more likely to be obese, and more likely to have a higher Elixhauser Comorbidity Index than Figure. Relative risks and adjusted marginal percentages of COVID-19 testing, hospitalizations, and receipt of intensive-level care, by race/ethnicity. All relative risks and adjusted marginal percentages were estimated using robust Poisson regression and included the log of follow-up days as offset to account for differential follow-up (<5% were lost to follow-up). Analyses were done using SAS, version 9.4 (SAS Institute). The fully adjusted model adjusted for age, sex, comorbidity categories, Elixhauser Comorbidity Index (count of comorbidities documented within past 12 mo), and body mass index categories. No collinearity issues were observed when using the Elixhauser Comorbidity Index along with the 5 broad comorbidity categories that adjust for the independent effects of each respective disease category.

those with COVID-19 who did not experience these events (Table) . The COVID-19 outcomes also varied by race/ethnicity. We observed disparities across race/ethnicity for all outcomes before and after adjustment for age, sex, comorbidities, and body mass index. Patients of color were slightly more likely to be tested and to test positive or be diagnosed with COVID-19 than White patients but were substantially more likely to be hospitalized and to receive intensive-level care (Figure) . Hispanic patients had the highest RRs of being tested and testing positive or being diagnosed with COVID-19 compared with White patients; however, Pacific Islander, Black or African American, and Asian patients had higher RRs for severe COVID-19 outcomes than White patients (Figure) .

Discussion: Our results confirm findings from earlier in the pandemic that suggest that COVID-19 affects Hispanic, Black or African American, and Asian persons disproportionately (2) . We further provide evidence of the disproportionate effect of COVID-19 on Pacific Islanders. We show that even after adjustment for known COVID-19 risk factors, such as comorbidities and body mass index, persons of color continue to have a substantially higher risk for hospitalization and requiring intensivelevel care than White persons (1) (2) (3) .

A limitation of this study is that some KPSC members may have been tested outside the KPSC system, particularly early in the pandemic. We have no information on these results. We are, however, able to identify patients seeking COVID-19-related care after an outside test. These patients were given a COVID-19 diagnosis by their provider, often without receiving a second confirmatory test at KPSC. We could not identify COVID-19-related intensivelevel care that was delivered outside KPSC. Similar to other research on COVID-19 using KP data, we used only data from encounters within the KP system (2) . Inequities in deaths were not analyzed because some racial/ethnic groups had fewer than 10 cases.

Inequities in COVID-19 outcomes are a call to action for a culturally appropriate pandemic response and vaccination strategies that go beyond addressing comorbidities and account for factors like distrust in the medical system, resource constraints, language proficiency, and health literacy.

Racial and ethnic health disparities related to COVID-19

Racial disparities in COVID-19 testing and outcomes: retrospective cohort study in an integrated health system

Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization

Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data